IMPROVEMENT OF NUTRITIONAL CONDITIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS STARTING FIRST DISEASE MODIFYING ANTI-RHEUMATIC DRUGS

被引:0
|
作者
Kobayashi, D. [1 ,2 ]
Ito, S. [2 ]
Hasegawa, E. [1 ,2 ]
Narita, I. [1 ]
Nakazono, K. [2 ]
机构
[1] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata, Japan
[2] Niigata Rheumat Ctr, Rheumatol, Shibata, Japan
关键词
D O I
10.1136/annrheumdis-2018-eular.2664
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT0130
引用
收藏
页码:927 / 927
页数:1
相关论文
共 50 条
  • [21] SECONDARY SARCOPENIA IN RHEUMATOID ARTHRITIS PATIENTS TREATED BY BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Hasegawa, Eriko
    Ito, Satoshi
    Kurosawa, Yoichi
    Kobayashi, Daisuke
    Abe, Asami
    Otani, Hiroshi
    Nakazono, Kiyoshi
    Murasawa, Akira
    Narita, Ichiei
    Ishikawa, Hajime
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1622 - 1622
  • [22] Predictors of Starting and Stopping Disease Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis: A 23 Year Longitudinal Cohort.
    Solomon, Daniel H.
    Yelin, Edward
    Katz, Jeffrey N.
    Tonner, Chris
    Brookhart, M. Alan
    Kim, Seoyoung C.
    Lu, Bing
    Ayanian, John Z.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S784 - S784
  • [23] Safety, cost and effectiveness issues with disease modifying anti-rheumatic drugs in rheumatoid arthritis
    Fries, JF
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 : 86 - 89
  • [24] THE MODERATING EFFECTS OF DEPRESSION ON BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS
    Rathbun, A. M.
    Harrold, L. R.
    Reed, G. W.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 631 - 631
  • [25] USE OF DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS FOR RHEUMATOID ARTHRITIS IN QUEBEC, CANADA
    Roussy, J. P.
    Bessette, L.
    Bernatsky, S.
    Rahme, E.
    Legare, J.
    Lachaine, J.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A316 - A316
  • [26] Use of Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in Quebec, Canada
    Roussy, Jean-Pascal
    Bessette, Louis
    Bernatsky, Sasha
    Rahme, Elham
    Legare, Jean
    Lachaine, Jean
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S855 - S855
  • [27] USE OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS AND RISK OF MULTIPLE MYELOMA IN RHEUMATOID ARTHRITIS
    Tokareva, Y.
    Peterson, A.
    Baraff, A.
    Smith, N.
    Coffey, D.
    Weiss, N.
    Singh, N.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (01) : NP642 - NP643
  • [28] Effectiveness of sequential biologic and targeted disease modifying anti-rheumatic drugs for rheumatoid arthritis
    Zhao, Sizheng Steven
    Kearlsey-Fleet, Lianne
    Bosworth, Ailsa
    Watson, Kath
    Hyrich, Kimme L.
    [J]. RHEUMATOLOGY, 2022, 61 (12) : 4678 - 4686
  • [29] ADVERSE DRUG REACTIONS ASSOCIATED WITH THE USE OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Machado, J.
    Ruiz, A.
    Machado-Duque, M.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A153 - A153
  • [30] Predictors at Diagnosis for Start of Biologic Disease Modifying Anti-Rheumatic Drugs in Patients with Early Rheumatoid Arthritis
    Hameed, M.
    Exarchou, S.
    Eberhard, A.
    Sharma, A.
    Bergstrom, U.
    Einarsson, J.
    Turesson, C.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 : 67 - 68